Loading insider details...
Beta
Latest Form 4 (Oct 15, 2026): Sale of 10,000 CUE shares, $275.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 15, 2026 | Cue Biopharma, Inc. (CUE) | Sale | 10,000 | $275.0K |
| Aug 15, 2026 | Cue Biopharma, Inc. (CUE) | Exercise/Conversion | 109,179 | n/a |
| Jul 30, 2026 | Cue Biopharma, Inc. (CUE) | Grant/Award | 90,906 | $1000.0K |
| Jul 10, 2026 | Cue Biopharma, Inc. (CUE) | Grant/Award | 327,537 | n/a |
| May 7, 2026 | Cue Biopharma, Inc. (CUE) | Grant/Award | 327,537 | n/a |
| May 15, 2025 | Surrozen, Inc./DE (SRZN) | Grant/Award | 1,333 | n/a |
| Jun 7, 2024 | Surrozen, Inc./DE (SRZN) | Grant/Award | 1,333 | n/a |
| Apr 3, 2024 | ACELYRIN, Inc. (SLRN) | Sale | 9,961 | $66.0K |
| Feb 22, 2024 | ACELYRIN, Inc. (SLRN) | Sale | 15,701 | $119.4K |
| Jan 11, 2024 | ACELYRIN, Inc. (SLRN) | Grant/Award | 964,829 | n/a |